Loading...
Header Logo
Keywords
Last Name
Institution

Professor Victor Nussenzweig

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zhang M, Mishra S, Sakthivel R, Fontoura BM, Nussenzweig V. UIS2: A Unique Phosphatase Required for the Development of Plasmodium Liver Stages. PLoS Pathog. 2016 Jan; 12(1):e1005370. PMID: 26735921.
      View in: PubMed
    2. Huang J, Li X, Coelho-dos-Reis JG, Zhang M, Mitchell R, Nogueira RT, Tsao T, Noe AR, Ayala R, Sahi V, Gutierrez GM, Nussenzweig V, Wilson JM, Nardin EH, Nussenzweig RS, Tsuji M. Human immune system mice immunized with Plasmodium falciparum circumsporozoite protein induce protective human humoral immunity against malaria. J Immunol Methods. 2015 Dec; 427:42-50. PMID: 26410104.
      View in: PubMed
    3. Nemetski SM, Cardozo TJ, Bosch G, Weltzer R, O'Malley K, Ejigiri I, Kumar KA, Buscaglia CA, Nussenzweig V, Sinnis P, Levitskaya J, Bosch J. Inhibition by stabilization: targeting the Plasmodium falciparum aldolase-TRAP complex. Malar J. 2015 Aug 20; 14:324. PMID: 26289816.
      View in: PubMed
    4. Teixeira LH, Tararam CA, Lasaro MO, Camacho AG, Ersching J, Leal MT, Herrera S, Bruna-Romero O, Soares IS, Nussenzweig RS, Ertl HC, Nussenzweig V, Rodrigues MM. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents. Infect Immun. 2014 Feb; 82(2):793-807. PMID: 24478093.
      View in: PubMed
    5. Zhang M, Joyce BR, Sullivan WJ, Nussenzweig V. Translational control in Plasmodium and toxoplasma parasites. Eukaryot Cell. 2013 Feb; 12(2):161-7. PMID: 23243065.
      View in: PubMed
    6. Rudra JS, Mishra S, Chong AS, Mitchell RA, Nardin EH, Nussenzweig V, Collier JH. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials. 2012 Sep; 33(27):6476-84. PMID: 22695068.
      View in: PubMed
    7. Zhang M, Mishra S, Sakthivel R, Rojas M, Ranjan R, Sullivan WJ, Fontoura BM, Ménard R, Dever TE, Nussenzweig V. PK4, a eukaryotic initiation factor 2a(eIF2a) kinase, is essential for the development of the erythrocytic cycle of Plasmodium. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3956-61. PMID: 22355110.
      View in: PubMed
    8. Mishra S, Nussenzweig RS, Nussenzweig V. Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity. J Immunol Methods. 2012 Mar 30; 377(1-2):47-52. PMID: 22306356.
      View in: PubMed
    9. Nussenzweig V, Good MF, Hill AV. Mixed results for a malaria vaccine. Nat Med. 2011 Dec 06; 17(12):1560-1. PMID: 22146460.
      View in: PubMed
    10. Camacho AG, Teixeira LH, Bargieri DY, Boscardin SB, Soares IS, Nussenzweig RS, Nussenzweig V, Rodrigues MM. TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium. Mem Inst Oswaldo Cruz. 2011 Aug; 106 Suppl 1:167-71. PMID: 21881771.
      View in: PubMed
    11. Mishra S, Rai U, Shiratsuchi T, Li X, Vanloubbeeck Y, Cohen J, Nussenzweig RS, Winzeler EA, Tsuji M, Nussenzweig V. Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine. 2011 Oct 06; 29(43):7335-42. PMID: 21807053.
      View in: PubMed
    12. Zhang M, Fennell C, Ranford-Cartwright L, Sakthivel R, Gueirard P, Meister S, Caspi A, Doerig C, Nussenzweig RS, Tuteja R, Sullivan WJ, Roos DS, Fontoura BM, Ménard R, Winzeler EA, Nussenzweig V. The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands. J Exp Med. 2010 Jul 05; 207(7):1465-74. PMID: 20584882.
      View in: PubMed
    13. Singh AP, Zhang Y, No JH, Docampo R, Nussenzweig V, Oldfield E. Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth. Antimicrob Agents Chemother. 2010 Jul; 54(7):2987-93. PMID: 20457823.
      View in: PubMed
    14. Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A. From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin. 2010 Jan; 6(1):90-6. PMID: 19806009.
      View in: PubMed
    15. Kubler-Kielb J, Majadly F, Biesova Z, Mocca CP, Guo C, Nussenzweig R, Nussenzweig V, Mishra S, Wu Y, Miller LH, Keith JM, Liu TY, Robbins JB, Schneerson R. A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates. Proc Natl Acad Sci U S A. 2010 Jan 19; 107(3):1172-7. PMID: 20080619.
      View in: PubMed
    16. Kumar KA, Baxter P, Tarun AS, Kappe SH, Nussenzweig V. Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS One. 2009; 4(2):e4480. PMID: 19214236.
      View in: PubMed
    17. Ménard R, Heussler V, Yuda M, Nussenzweig V. Plasmodium pre-erythrocytic stages: what's new? Trends Parasitol. 2008 Dec; 24(12):564-9. PMID: 18929511.
      View in: PubMed
    18. Zhou Y, Ramachandran V, Kumar KA, Westenberger S, Refour P, Zhou B, Li F, Young JA, Chen K, Plouffe D, Henson K, Nussenzweig V, Carlton J, Vinetz JM, Duraisingh MT, Winzeler EA. Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One. 2008 Feb 13; 3(2):e1570. PMID: 18270564.
      View in: PubMed
    19. Oliveira GA, Kumar KA, Calvo-Calle JM, Othoro C, Altszuler D, Nussenzweig V, Nardin EH. Class II-restricted protective immunity induced by malaria sporozoites. Infect Immun. 2008 Mar; 76(3):1200-6. PMID: 18160479.
      View in: PubMed
    20. Singh AP, Buscaglia CA, Wang Q, Levay A, Nussenzweig DR, Walker JR, Winzeler EA, Fujii H, Fontoura BM, Nussenzweig V. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell. 2007 Nov 02; 131(3):492-504. PMID: 17981117.
      View in: PubMed
    21. Kumar KA, Garcia CR, Chandran VR, Van Rooijen N, Zhou Y, Winzeler E, Nussenzweig V. Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity. Mol Biochem Parasitol. 2007 Nov; 156(1):32-40. PMID: 17714805.
      View in: PubMed
    22. Bosch J, Buscaglia CA, Krumm B, Ingason BP, Lucas R, Roach C, Cardozo T, Nussenzweig V, Hol WG. Aldolase provides an unusual binding site for thrombospondin-related anonymous protein in the invasion machinery of the malaria parasite. Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7015-20. PMID: 17426153.
      View in: PubMed
    23. Buscaglia CA, Hol WG, Nussenzweig V, Cardozo T. Modeling the interaction between aldolase and the thrombospondin-related anonymous protein, a key connection of the malaria parasite invasion machinery. Proteins. 2007 Feb 15; 66(3):528-37. PMID: 17154157.
      View in: PubMed
    24. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, Nussenzweig V. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature. 2006 Dec 14; 444(7121):937-40. PMID: 17151604.
      View in: PubMed
    25. Buscaglia CA, Penesetti D, Tao M, Nussenzweig V. Characterization of an aldolase-binding site in the Wiskott-Aldrich syndrome protein. J Biol Chem. 2006 Jan 20; 281(3):1324-31. PMID: 16278221.
      View in: PubMed
    26. Wang Q, Fujioka H, Nussenzweig V. Mutational analysis of the GPI-anchor addition sequence from the circumsporozoite protein of Plasmodium. Cell Microbiol. 2005 Nov; 7(11):1616-26. PMID: 16207248.
      View in: PubMed
    27. Wang Q, Fujioka H, Nussenzweig V. Exit of Plasmodium sporozoites from oocysts is an active process that involves the circumsporozoite protein. PLoS Pathog. 2005 Sep; 1(1):e9. PMID: 16201021.
      View in: PubMed
    28. Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice CM, Nussenzweig RS. Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med. 2005 Jan 17; 201(2):201-9. PMID: 15657290.
      View in: PubMed
    29. Bhanot P, Schauer K, Coppens I, Nussenzweig V. A surface phospholipase is involved in the migration of plasmodium sporozoites through cells. J Biol Chem. 2005 Feb 25; 280(8):6752-60. PMID: 15590623.
      View in: PubMed
    30. Kumar KA, Oliveira GA, Edelman R, Nardin E, Nussenzweig V. Quantitative Plasmodium sporozoite neutralization assay (TSNA). J Immunol Methods. 2004 Sep; 292(1-2):157-64. PMID: 15350520.
      View in: PubMed
    31. Wang Q, Brown S, Roos DS, Nussenzweig V, Bhanot P. Transcriptome of axenic liver stages of Plasmodium yoelii. Mol Biochem Parasitol. 2004 Sep; 137(1):161-8. PMID: 15279962.
      View in: PubMed
    32. Kappe SH, Buscaglia CA, Bergman LW, Coppens I, Nussenzweig V. Apicomplexan gliding motility and host cell invasion: overhauling the motor model. Trends Parasitol. 2004 Jan; 20(1):13-6. PMID: 14700584.
      View in: PubMed
    33. Kappe SH, Buscaglia CA, Nussenzweig V. Plasmodium sporozoite molecular cell biology. Annu Rev Cell Dev Biol. 2004; 20:29-59. PMID: 15473834.
      View in: PubMed
    34. Buscaglia CA, Coppens I, Hol WG, Nussenzweig V. Sites of interaction between aldolase and thrombospondin-related anonymous protein in plasmodium. Mol Biol Cell. 2003 Dec; 14(12):4947-57. PMID: 14595113.
      View in: PubMed
    35. Bhanot P, Frevert U, Nussenzweig V, Persson C. Defective sorting of the thrombospondin-related anonymous protein (TRAP) inhibits Plasmodium infectivity. Mol Biochem Parasitol. 2003 Feb; 126(2):263-73. PMID: 12615325.
      View in: PubMed
    36. Bergman LW, Kaiser K, Fujioka H, Coppens I, Daly TM, Fox S, Matuschewski K, Nussenzweig V, Kappe SH. Myosin A tail domain interacting protein (MTIP) localizes to the inner membrane complex of Plasmodium sporozoites. J Cell Sci. 2003 Jan 01; 116(Pt 1):39-49. PMID: 12456714.
      View in: PubMed
    37. Persson C, Oliveira GA, Sultan AA, Bhanot P, Nussenzweig V, Nardin E. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. J Immunol. 2002 Dec 15; 169(12):6681-5. PMID: 12471098.
      View in: PubMed
    38. Bhanot P, Nussenzweig V. Plasmodium yoelii sporozoites infect Syndecan-1 deficient mice. Mol Biochem Parasitol. 2002 Aug 28; 123(2):143-4. PMID: 12270630.
      View in: PubMed
    39. Matuschewski K, Ross J, Brown SM, Kaiser K, Nussenzweig V, Kappe SH. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J Biol Chem. 2002 Nov 01; 277(44):41948-53. PMID: 12177071.
      View in: PubMed
    40. Thathy V, Fujioka H, Gantt S, Nussenzweig R, Nussenzweig V, Ménard R. Levels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphology. EMBO J. 2002 Apr 02; 21(7):1586-96. PMID: 11927543.
      View in: PubMed
    41. Matuschewski K, Nunes AC, Nussenzweig V, Ménard R. Plasmodium sporozoite invasion into insect and mammalian cells is directed by the same dual binding system. EMBO J. 2002 Apr 02; 21(7):1597-606. PMID: 11927544.
      View in: PubMed
    42. Kappe SH, Gardner MJ, Brown SM, Ross J, Matuschewski K, Ribeiro JM, Adams JH, Quackenbush J, Cho J, Carucci DJ, Hoffman SL, Nussenzweig V. Exploring the transcriptome of the malaria sporozoite stage. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9895-900. PMID: 11493695.
      View in: PubMed
    43. Mota MM, Thathy V, Nussenzweig RS, Nussenzweig V. Gene targeting in the rodent malaria parasite Plasmodium yoelii. Mol Biochem Parasitol. 2001 Apr 06; 113(2):271-8. PMID: 11295181.
      View in: PubMed
    44. Sultan AA, Thathy V, de Koning-Ward TF, Nussenzweig V. Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker. Mol Biochem Parasitol. 2001 Mar; 113(1):151-6. PMID: 11254963.
      View in: PubMed
    45. de Diego JL, Katz JM, Marshall P, Gutiérrez B, Manning JE, Nussenzweig V, González J. The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochemistry. 2001 Jan 30; 40(4):1053-62. PMID: 11170428.
      View in: PubMed
    46. Matuschewski K, Mota MM, Pinder JC, Nussenzweig V, Kappe SH. Identification of the class XIV myosins Pb-MyoA and Py-MyoA and expression in Plasmodium sporozoites. Mol Biochem Parasitol. 2001 Jan 15; 112(1):157-61. PMID: 11166399.
      View in: PubMed
    47. Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodríguez A. Migration of Plasmodium sporozoites through cells before infection. Science. 2001 Jan 05; 291(5501):141-4. PMID: 11141568.
      View in: PubMed
    48. Mortara RA, Minelli LM, Vandekerckhove F, Nussenzweig V, Ramalho-Pinto FJ. Phosphatidylinositol-specific phospholipase C (PI-PLC) cleavage of GPI-anchored surface molecules of Trypanosoma cruzi triggers in vitro morphological reorganization of trypomastigotes. J Eukaryot Microbiol. 2001 Jan-Feb; 48(1):27-37. PMID: 11249190.
      View in: PubMed
    49. Ménard R, Nussenzweig V. Structure-function analysis of malaria proteins by gene targeting. Parasitol Today. 2000 Jun; 16(6):222-4. PMID: 10827424.
      View in: PubMed
    50. Gantt S, Persson C, Rose K, Birkett AJ, Abagyan R, Nussenzweig V. Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo. Infect Immun. 2000 Jun; 68(6):3667-73. PMID: 10816526.
      View in: PubMed
    51. Marshall P, Rohlmann A, Nussenzweig V, Herz J, Sinnis P. Plasmodium sporozoites invade cells with targeted deletions in the LDL receptor related protein. Mol Biochem Parasitol. 2000 Mar 05; 106(2):293-8. PMID: 10699258.
      View in: PubMed
    52. Kappe S, Bruderer T, Gantt S, Fujioka H, Nussenzweig V, Ménard R. Conservation of a gliding motility and cell invasion machinery in Apicomplexan parasites. J Cell Biol. 1999 Nov 29; 147(5):937-44. PMID: 10579715.
      View in: PubMed
    53. Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. Parassitologia. 1999 Sep; 41(1-3):397-402. PMID: 10697892.
      View in: PubMed
    54. Sultan AA, Thathy V, Nussenzweig V, Ménard R. Green fluorescent protein as a marker in Plasmodium berghei transformation. Infect Immun. 1999 May; 67(5):2602-6. PMID: 10225926.
      View in: PubMed
    55. Raper J, Fung R, Ghiso J, Nussenzweig V, Tomlinson S. Characterization of a novel trypanosome lytic factor from human serum. Infect Immun. 1999 Apr; 67(4):1910-6. PMID: 10085035.
      View in: PubMed
    56. Gantt SM, Myung JM, Briones MR, Li WD, Corey EJ, Omura S, Nussenzweig V, Sinnis P. Proteasome inhibitors block development of Plasmodium spp. Antimicrob Agents Chemother. 1998 Oct; 42(10):2731-8. PMID: 9756786.
      View in: PubMed
    57. Coppel RL, Brown GV, Nussenzweig V. Adhesive proteins of the malaria parasite. Curr Opin Microbiol. 1998 Aug; 1(4):472-81. PMID: 10066512.
      View in: PubMed
    58. Muranjan M, Nussenzweig V, Tomlinson S. Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J Biol Chem. 1998 Feb 13; 273(7):3884-7. PMID: 9461571.
      View in: PubMed
    59. Tomlinson S, Nussenzweig V. Human alternative complement pathway-mediated lysis of rabbit erythrocytes is enhanced by natural anti-Galalpha1-3Gal antibodies. J Immunol. 1997 Dec 01; 159(11):5606-9. PMID: 9548503.
      View in: PubMed
    60. Sultan AA, Briones MR, Gerwin N, Carroll MC, Nussenzweig V. Sporozoites of Plasmodium yoelii infect mice with targeted deletions in ICAM-1 and ICAM-2 or complement components C3 and C4. Mol Biochem Parasitol. 1997 Sep; 88(1-2):263-6. PMID: 9274888.
      View in: PubMed
    61. Sultan AA, Thathy V, Frevert U, Robson KJ, Crisanti A, Nussenzweig V, Nussenzweig RS, Ménard R. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell. 1997 Aug 08; 90(3):511-22. PMID: 9267031.
      View in: PubMed
    62. Tomlinson S, Muranjan M, Nussenzweig V, Raper J. Haptoglobin-related protein and apolipoprotein AI are components of the two trypanolytic factors in human serum. Mol Biochem Parasitol. 1997 May; 86(1):117-20. PMID: 9178275.
      View in: PubMed
    63. Nussenzweig V. Malaria sporozoites and chylomicron remnants compete for binding sites in the liver. Behring Inst Mitt. 1997 Mar; (99):85-9. PMID: 9303206.
      View in: PubMed
    64. Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S. Mapping the active site of CD59. J Exp Med. 1997 Feb 17; 185(4):745-53. PMID: 9034152.
      View in: PubMed
    65. Ménard R, Sultan AA, Cortes C, Altszuler R, van Dijk MR, Janse CJ, Waters AP, Nussenzweig RS, Nussenzweig V. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature. 1997 Jan 23; 385(6614):336-40. PMID: 9002517.
      View in: PubMed
    66. González J, Frevert U, Corey EJ, Nussenzweig V, Eichinger D. Proteasome function is required for encystation of Entamoeba invadens. Arch Med Res. 1997; 28 Spec No:139-40. PMID: 9033045.
      View in: PubMed
    67. González J, Ramalho-Pinto FJ, Frevert U, Ghiso J, Tomlinson S, Scharfstein J, Corey EJ, Nussenzweig V. Proteasome activity is required for the stage-specific transformation of a protozoan parasite. J Exp Med. 1996 Nov 01; 184(5):1909-18. PMID: 8920878.
      View in: PubMed
    68. Marshall P, Hasegawa A, Davidson EA, Nussenzweig V, Whitlow M. Interaction between complement proteins C5b-7 and erythrocyte membrane sialic acid. J Exp Med. 1996 Oct 01; 184(4):1225-32. PMID: 8879193.
      View in: PubMed
    69. Sinnis P, Willnow TE, Briones MR, Herz J, Nussenzweig V. Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J Exp Med. 1996 Sep 01; 184(3):945-54. PMID: 9064354.
      View in: PubMed
    70. Briones MR, Tsuji M, Nussenzweig V. The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes. Mol Biochem Parasitol. 1996 Apr; 77(1):7-17. PMID: 8784767.
      View in: PubMed
    71. Raper J, Nussenzweig V, Tomlinson S. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J Exp Med. 1996 Mar 01; 183(3):1023-9. PMID: 8642243.
      View in: PubMed
    72. Frevert U, Sinnis P, Esko JD, Nussenzweig V. Cell surface glycosaminoglycans are not obligatory for Plasmodium berghei sporozoite invasion in vitro. Mol Biochem Parasitol. 1996 Feb-Mar; 76(1-2):257-66. PMID: 8920011.
      View in: PubMed
    73. Raper J, Nussenzweig V, Tomlinson S. Lack of correlation between haptoglobin concentration and trypanolytic activity of normal human serum. Mol Biochem Parasitol. 1996 Feb-Mar; 76(1-2):337-8. PMID: 8920024.
      View in: PubMed
    74. Tomlinson S, Vandekerckhove F, Frevert U, Nussenzweig V. The induction of Trypanosoma cruzi trypomastigote to amastigote transformation by low pH. Parasitology. 1995 Jun; 110 ( Pt 5):547-54. PMID: 7541124.
      View in: PubMed
    75. Tomlinson S, Jansen AM, Koudinov A, Ghiso JA, Choi-Miura NH, Rifkin MR, Ohtaki S, Nussenzweig V. High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum. Mol Biochem Parasitol. 1995 Mar; 70(1-2):131-8. PMID: 7637693.
      View in: PubMed
    76. Medina-Acosta E, Franco AM, Jansen AM, Sampol M, Nevés N, Pontes-de-Carvalho L, Grimaldi Jùnior G, Nussenzweig V. Trans-sialidase and sialidase activities discriminate between morphologically indistinguishable trypanosomatids. Eur J Biochem. 1994 Oct 01; 225(1):333-9. PMID: 7925453.
      View in: PubMed
    77. Tomlinson S, Pontes de Carvalho LC, Vandekerckhove F, Nussenzweig V. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol. 1994 Oct 01; 153(7):3141-7. PMID: 8089492.
      View in: PubMed
    78. Sinnis P, Clavijo P, Fenyö D, Chait BT, Cerami C, Nussenzweig V. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med. 1994 Jul 01; 180(1):297-306. PMID: 8006589.
      View in: PubMed
    79. Rénia L, Rodrigues MM, Nussenzweig V. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology. 1994 May; 82(1):164-8. PMID: 7913914.
      View in: PubMed
    80. Kaslow DC, Nussenzweig V, Miller L. Meeting on Parasites and the invertebrate vector. John D and Catherine T MacArthur Foundation, November 18-21, 1993. Mem Inst Oswaldo Cruz. 1994 Apr-Jun; 89(2):279-95. PMID: 7885258.
      View in: PubMed
    81. Tomlinson S, Whitlow MB, Nussenzweig V. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9. J Immunol. 1994 Feb 15; 152(4):1927-34. PMID: 7509832.
      View in: PubMed
    82. Cerami C, Frevert U, Sinnis P, Takacs B, Nussenzweig V. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J Exp Med. 1994 Feb 01; 179(2):695-701. PMID: 8294876.
      View in: PubMed
    83. Schenkman S, Eichinger D, Pereira ME, Nussenzweig V. Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol. 1994; 48:499-523. PMID: 7826016.
      View in: PubMed
    84. Pontes-de-Carvalho LC, Tomlinson S, Nussenzweig V. Trypanosoma rangeli sialidase lacks trans-sialidase activity. Mol Biochem Parasitol. 1993 Nov; 62(1):19-25. PMID: 8114822.
      View in: PubMed
    85. Frevert U, Sinnis P, Cerami C, Shreffler W, Takacs B, Nussenzweig V. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med. 1993 May 01; 177(5):1287-98. PMID: 8478608.
      View in: PubMed
    86. Pontes de Carvalho LC, Tomlinson S, Vandekerckhove F, Bienen EJ, Clarkson AB, Jiang MS, Hart GW, Nussenzweig V. Characterization of a novel trans-sialidase of Trypanosoma brucei procyclic trypomastigotes and identification of procyclin as the main sialic acid acceptor. J Exp Med. 1993 Feb 01; 177(2):465-74. PMID: 8426115.
      View in: PubMed
    87. Whitlow M, Iida K, Marshall P, Silber R, Nussenzweig V. Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Blood. 1993 Jan 15; 81(2):510-6. PMID: 7678519.
      View in: PubMed
    88. Rénia L, Xia D, Samols D, Nussenzweig V. Transgenic mice expressing C-reactive protein are susceptible to infection with Plasmodium yoelii sporozoites. Infect Immun. 1993 Jan; 61(1):348-9. PMID: 8418060.
      View in: PubMed
    89. Borst P, Nussenzweig V. Molecular parasitology at Woods Hole. Cell. 1992 Dec 11; 71(6):895-9. PMID: 1458539.
      View in: PubMed
    90. Vandekerckhove F, Schenkman S, Pontes de Carvalho L, Tomlinson S, Kiso M, Yoshida M, Hasegawa A, Nussenzweig V. Substrate specificity of the Trypanosoma cruzi trans-sialidase. Glycobiology. 1992 Dec; 2(6):541-8. PMID: 1282052.
      View in: PubMed
    91. Tomlinson S, Pontes de Carvalho L, Vandekerckhove F, Nussenzweig V. Resialylation of sialidase-treated sheep and human erythrocytes by Trypanosoma cruzi trans-sialidase: restoration of complement resistance of desialylated sheep erythrocytes. Glycobiology. 1992 Dec; 2(6):549-51. PMID: 1472761.
      View in: PubMed
    92. Uemura H, Schenkman S, Nussenzweig V, Eichinger D. Only some members of a gene family in Trypanosoma cruzi encode proteins that express both trans-sialidase and neuraminidase activities. EMBO J. 1992 Nov; 11(11):3837-44. PMID: 1396577.
      View in: PubMed
    93. Cerami C, Frevert U, Sinnis P, Takacs B, Clavijo P, Santos MJ, Nussenzweig V. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell. 1992 Sep 18; 70(6):1021-33. PMID: 1326407.
      View in: PubMed
    94. Cerami C, Kwakye-Berko F, Nussenzweig V. Binding of malarial circumsporozoite protein to sulfatides [Gal(3-SO4)beta 1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II. Mol Biochem Parasitol. 1992 Aug; 54(1):1-12. PMID: 1518521.
      View in: PubMed
    95. Frevert U, Schenkman S, Nussenzweig V. Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infect Immun. 1992 Jun; 60(6):2349-60. PMID: 1375197.
      View in: PubMed
    96. Schenkman S, Kurosaki T, Ravetch JV, Nussenzweig V. Evidence for the participation of the Ssp-3 antigen in the invasion of nonphagocytic mammalian cells by Trypanosoma cruzi. J Exp Med. 1992 Jun 01; 175(6):1635-41. PMID: 1534115.
      View in: PubMed
    97. Diaz C, Nussenzweig V, Gonzalez A. An improved polymerase chain reaction assay to detect Trypanosoma cruzi in blood. Am J Trop Med Hyg. 1992 May; 46(5):616-23. PMID: 1599057.
      View in: PubMed
    98. Schenkman S, Pontes de Carvalho L, Nussenzweig V. Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes. J Exp Med. 1992 Feb 01; 175(2):567-75. PMID: 1732417.
      View in: PubMed
    99. Iida K, Whitlow MB, Nussenzweig V. Membrane vesiculation protects erythrocytes from destruction by complement. J Immunol. 1991 Oct 15; 147(8):2638-42. PMID: 1918984.
      View in: PubMed
    100. Schenkman S, Jiang MS, Hart GW, Nussenzweig V. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell. 1991 Jun 28; 65(7):1117-25. PMID: 1712251.
      View in: PubMed
    101. Hoffman SL, Nussenzweig V, Sadoff JC, Nussenzweig RS. Progress toward malaria preerythrocytic vaccines. Science. 1991 Apr 26; 252(5005):520-1. PMID: 2020852.
      View in: PubMed
    102. Schenkman S, Robbins ES, Nussenzweig V. Attachment of Trypanosoma cruzi to mammalian cells requires parasite energy, and invasion can be independent of the target cell cytoskeleton. Infect Immun. 1991 Feb; 59(2):645-54. PMID: 1987081.
      View in: PubMed
    103. Schenkman S, Diaz C, Nussenzweig V. Attachment of Trypanosoma cruzi trypomastigotes to receptors at restricted cell surface domains. Exp Parasitol. 1991 Jan; 72(1):76-86. PMID: 1993466.
      View in: PubMed
    104. Yoshida N, Di Santi SM, Dutra AP, Nussenzweig RS, Nussenzweig V, Enea V. Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. Exp Parasitol. 1990 Nov; 71(4):386-92. PMID: 1699781.
      View in: PubMed
    105. Nussenzweig V, Nussenzweig RS. Progress toward a malaria vaccine. Hosp Pract (Off Ed). 1990 Sep 15; 25(9):45-52, 55-7. PMID: 2118918.
      View in: PubMed
    106. Whitlow MB, Iida K, Stefanova I, Bernard A, Nussenzweig V. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement. Cell Immunol. 1990 Mar; 126(1):176-84. PMID: 1689219.
      View in: PubMed
    107. Ley V, Robbins ES, Nussenzweig V, Andrews NW. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J Exp Med. 1990 Feb 01; 171(2):401-13. PMID: 2406362.
      View in: PubMed
    108. Zimmermann A, Gerber H, Nussenzweig V, Isliker H. Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction. Virchows Arch A Pathol Anat Histopathol. 1990; 417(4):299-304. PMID: 1700536.
      View in: PubMed
    109. Nussenzweig V, Nussenzweig S. Sporozoite malaria vaccine. Where do we stand? Ann Parasitol Hum Comp. 1990; 65 Suppl 1:49-52. PMID: 1702271.
      View in: PubMed
    110. Tam JP, Clavijo P, Lu YA, Nussenzweig V, Nussenzweig R, Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med. 1990 Jan 01; 171(1):299-306. PMID: 1688609.
      View in: PubMed
    111. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 1989 Sep 28; 341(6240):323-6. PMID: 2477703.
      View in: PubMed
    112. Satterthwait AC, Arrhenius T, Hagopian RA, Zavala F, Nussenzweig V, Lerner RA. The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens. Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12; 323(1217):565-72. PMID: 2569211.
      View in: PubMed
    113. Nussenzweig RS, Nussenzweig V. Antisporozoite vaccine for malaria: experimental basis and current status. Rev Infect Dis. 1989 May-Jun; 11 Suppl 3:S579-85. PMID: 2669101.
      View in: PubMed
    114. Iida K, Whitlow MB, Nussenzweig V. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components. J Exp Med. 1989 Mar 01; 169(3):881-91. PMID: 2494292.
      View in: PubMed
    115. Andrews NW, Einstein M, Nussenzweig V. Presence of antibodies to the major surface glycoprotein of Trypanosoma cruzi amastigotes in sera from Chagasic patients. Am J Trop Med Hyg. 1989 Jan; 40(1):46-9. PMID: 2492776.
      View in: PubMed
    116. Nussenzweig V, Nussenzweig RS. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol. 1989; 45:283-334. PMID: 2665440.
      View in: PubMed
    117. Nussenzweig V, Nussenzweig RS. Circumsporozoite proteins of malaria parasites. Bull Mem Acad R Med Belg. 1989; 144(11):493-504. PMID: 2517878.
      View in: PubMed
    118. Romero PJ, Tam JP, Schlesinger D, Clavijo P, Gibson H, Barr PJ, Nussenzweig RS, Nussenzweig V, Zavala F. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei. Eur J Immunol. 1988 Dec; 18(12):1951-7. PMID: 2464495.
      View in: PubMed
    119. Andrews NW, Schenkman S, Ley V, Whitlow MB, Robbins ES, Nussenzweig V. Trypanosoma cruzi: mechanisms of cell-invasion and intracellular survival. Mem Inst Oswaldo Cruz. 1988 Nov; 83 Suppl 1:452-5. PMID: 3151005.
      View in: PubMed
    120. Andrews NW, Robbins E, Ley V, Nussenzweig V. Stage-specific surface antigens during the morphogenesis of Trypanosoma cruzi: developmentally regulated expression of a glycosyl-phosphatidylinositol anchored glycoprotein of amastigotes. Mem Inst Oswaldo Cruz. 1988 Nov; 83 Suppl 1:561-2. PMID: 2978169.
      View in: PubMed
    121. Werth VP, Ivanov IE, Nussenzweig V. Decay-accelerating factor in human skin is associated with elastic fibers. J Invest Dermatol. 1988 Nov; 91(5):511-6. PMID: 2459267.
      View in: PubMed
    122. Schenkman S, Andrews NW, Nussenzweig V, Robbins ES. Trypanosoma cruzi invade a mammalian epithelial cell in a polarized manner. Cell. 1988 Oct 07; 55(1):157-65. PMID: 3139302.
      View in: PubMed
    123. Nussenzweig RS, Nussenzweig V. Malaria vaccine trials. Science. 1988 Sep 09; 241(4871):1278. PMID: 3413491.
      View in: PubMed
    124. Ley V, Andrews NW, Robbins ES, Nussenzweig V. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med. 1988 Aug 01; 168(2):649-59. PMID: 3045248.
      View in: PubMed
    125. Satterthwait AC, Arrhenius T, Hagopian RA, Zavala F, Nussenzweig V, Lerner RA. Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond. Vaccine. 1988 Apr; 6(2):99-103. PMID: 3291460.
      View in: PubMed
    126. Shak S, Davitz MA, Wolinsky ML, Nussenzweig V, Turner MJ, Gurnett A. Partial characterization of the cross-reacting determinant, a carbohydrate epitope shared by decay accelerating factor and the variant surface glycoprotein of the African Trypanosoma brucei. J Immunol. 1988 Mar 15; 140(6):2046-50. PMID: 2450138.
      View in: PubMed
    127. Andrews NW, Robbins ES, Ley V, Hong KS, Nussenzweig V. Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi. J Exp Med. 1988 Feb 01; 167(2):300-14. PMID: 3279152.
      View in: PubMed
    128. Andrews NW, Hong KS, Robbins ES, Nussenzweig V. Stage-specific surface antigens expressed during the morphogenesis of vertebrate forms of Trypanosoma cruzi. Exp Parasitol. 1987 Dec; 64(3):474-84. PMID: 3315736.
      View in: PubMed
    129. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987 Dec 17-23; 330(6149):664-6. PMID: 3120015.
      View in: PubMed
    130. Nardin EH, Barr PJ, Gibson HL, Collins WE, Nussenzweig RS, Nussenzweig V. Induction of sporozoite-specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein. Eur J Immunol. 1987 Dec; 17(12):1763-7. PMID: 3319650.
      View in: PubMed
    131. Caras IW, Weddell GN, Davitz MA, Nussenzweig V, Martin DW. Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science. 1987 Nov 27; 238(4831):1280-3. PMID: 2446389.
      View in: PubMed
    132. Zavala F, Tam JP, Barr PJ, Romero PJ, Ley V, Nussenzweig RS, Nussenzweig V. Synthetic peptide vaccine confers protection against murine malaria. J Exp Med. 1987 Nov 01; 166(5):1591-6. PMID: 3316473.
      View in: PubMed
    133. Davitz MA, Hereld D, Shak S, Krakow J, Englund PT, Nussenzweig V. A glycan-phosphatidylinositol-specific phospholipase D in human serum. Science. 1987 Oct 02; 238(4823):81-4. PMID: 2443973.
      View in: PubMed
    134. Schofield L, Ferreira A, Altszuler R, Nussenzweig V, Nussenzweig RS. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol. 1987 Sep 15; 139(6):2020-5. PMID: 2957445.
      View in: PubMed
    135. Medof ME, Gottlieb A, Kinoshita T, Hall S, Silber R, Nussenzweig V, Rosse WF. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest. 1987 Jul; 80(1):165-74. PMID: 2439544.
      View in: PubMed
    136. Vergara U, Ferreira A, Schellekens H, Nussenzweig V. Mechanism of escape of exoerythrocytic forms (EEF) of malaria parasites from the inhibitory effects of interferon-gamma. J Immunol. 1987 Jun 15; 138(12):4447-9. PMID: 3108391.
      View in: PubMed
    137. Kinoshita T, Rosenfeld SI, Nussenzweig V. A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes. J Immunol. 1987 May 01; 138(9):2994-8. PMID: 2437202.
      View in: PubMed
    138. Barr PJ, Gibson HL, Enea V, Arnot DE, Hollingdale MR, Nussenzweig V. Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine. J Exp Med. 1987 Apr 01; 165(4):1160-71. PMID: 3549959.
      View in: PubMed
    139. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med. 1987 Mar 01; 165(3):848-64. PMID: 2434600.
      View in: PubMed
    140. Davitz MA, Schlesinger D, Nussenzweig V. Isolation of decay accelerating factor (DAF) by a two-step procedure and determination of its N-terminal sequence. J Immunol Methods. 1987 Feb 26; 97(1):71-6. PMID: 2434569.
      View in: PubMed
    141. Ferreira A, Morimoto T, Altszuler R, Nussenzweig V. Use of a DNA probe to measure the neutralization of Plasmodium berghei sporozoites by a monoclonal antibody. J Immunol. 1987 Feb 15; 138(4):1256-9. PMID: 3543124.
      View in: PubMed
    142. Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW, Nussenzweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature. 1987 Feb 5-11; 325(6104):545-9. PMID: 2433596.
      View in: PubMed
    143. Davitz MA, Gurnett AM, Low MG, Turner MJ, Nussenzweig V. Decay-accelerating factor (DAF) shares a common carbohydrate determinant with the variant surface glycoprotein (VSG) of the African Trypanosoma brucei. J Immunol. 1987 Jan 15; 138(2):520-3. PMID: 2432127.
      View in: PubMed
    144. Miller LH, Howard RJ, Carter R, Good MF, Nussenzweig V, Nussenzweig RS. Research toward malaria vaccines. Science. 1986 Dec 12; 234(4782):1349-56. PMID: 2431481.
      View in: PubMed
    145. Eichinger DJ, Arnot DE, Tam JP, Nussenzweig V, Enea V. Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes. Mol Cell Biol. 1986 Nov; 6(11):3965-72. PMID: 2432395.
      View in: PubMed
    146. Kinoshita T, Medof ME, Hong K, Nussenzweig V. Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells. J Exp Med. 1986 Nov 01; 164(5):1377-88. PMID: 2430040.
      View in: PubMed
    147. Nussenzweig V, Nussenzweig RS. Development of a sporozoite malaria vaccine. Am J Trop Med Hyg. 1986 Jul; 35(4):678-88. PMID: 2425647.
      View in: PubMed
    148. Masuda A, Zavala F, Nussenzweig V, Nussenzweig RS. Monoclonal anti-gametocyte antibodies identify an antigen present in all blood stages of Plasmodium falciparum. Mol Biochem Parasitol. 1986 Jun; 19(3):213-22. PMID: 3526145.
      View in: PubMed
    149. Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, Collins WE, Nussenzweig RS, Nussenzweig V. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science. 1986 May 16; 232(4752):881-4. PMID: 3085218.
      View in: PubMed
    150. Kinoshita T, Medof ME, Nussenzweig V. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes. J Immunol. 1986 May 01; 136(9):3390-5. PMID: 2420889.
      View in: PubMed
    151. Ferreira A, Enea V, Morimoto T, Nussenzweig V. Infectivity of Plasmodium berghei sporozoites measured with a DNA probe. Mol Biochem Parasitol. 1986 May; 19(2):103-9. PMID: 3523238.
      View in: PubMed
    152. Davitz MA, Low MG, Nussenzweig V. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J Exp Med. 1986 May 01; 163(5):1150-61. PMID: 2422313.
      View in: PubMed
    153. Asch AS, Kinoshita T, Jaffe EA, Nussenzweig V. Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J Exp Med. 1986 Jan 01; 163(1):221-6. PMID: 2416869.
      View in: PubMed
    154. Nussenzweig V, Nussenzweig R. Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites. Ciba Found Symp. 1986; 119:150-63. PMID: 2426050.
      View in: PubMed
    155. Nussenzweig RS, Nussenzweig V. Development of a sporozoite vaccine. Parasitol Today. 1985 Dec; 1(6):150-2. PMID: 15275569.
      View in: PubMed
    156. Arnot DE, Barnwell JW, Tam JP, Nussenzweig V, Nussenzweig RS, Enea V. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science. 1985 Nov 15; 230(4727):815-8. PMID: 2414847.
      View in: PubMed
    157. Nussenzweig V, Nussenzweig RS. Malaria vaccine against sporozoites? Ann Inst Pasteur Immunol (1985). 1985 Nov-Dec; 136D(3):301-12. PMID: 3913382.
      View in: PubMed
    158. Zavala F, Masuda A, Graves PM, Nussenzweig V, Nussenzweig RS. Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J Immunol. 1985 Oct; 135(4):2790-3. PMID: 2411813.
      View in: PubMed
    159. Nussenzweig V, Nussenzweig RS. Circumsporozoite proteins of malaria parasites. Cell. 1985 Sep; 42(2):401-3. PMID: 2411417.
      View in: PubMed
    160. Kinoshita T, Medof ME, Silber R, Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med. 1985 Jul 01; 162(1):75-92. PMID: 2409211.
      View in: PubMed
    161. Zavala F, Tam JP, Hollingdale MR, Cochrane AH, Quakyi I, Nussenzweig RS, Nussenzweig V. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science. 1985 Jun 21; 228(4706):1436-40. PMID: 2409595.
      View in: PubMed
    162. Medof ME, Kinoshita T, Silber R, Nussenzweig V. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci U S A. 1985 May; 82(9):2980-4. PMID: 2581259.
      View in: PubMed
    163. Vergara U, Ruiz A, Ferreira A, Nussenzweig RS, Nussenzweig V. Conserved group-specific epitopes of the circumsporozoite proteins revealed by antibodies to synthetic peptides. J Immunol. 1985 May; 134(5):3445-8. PMID: 2580025.
      View in: PubMed
    164. Kinoshita T, Lavoie S, Nussenzweig V. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1). J Immunol. 1985 Apr; 134(4):2564-70. PMID: 3156184.
      View in: PubMed
    165. Vergara U, Gwadz R, Schlesinger D, Nussenzweig V, Ferreira A. Multiple non-repeated epitopes on the circumsporozoite protein of Plasmodium knowlesi. Mol Biochem Parasitol. 1985 Mar; 14(3):283-92. PMID: 2581134.
      View in: PubMed
    166. Zavala F, Hollingdale MR, Schwartz AL, Nussenzweig RS, Nussenzweig V. Immunoradiometric assay to measure the in vitro penetration of sporozoites of malaria parasites into hepatoma cells. J Immunol. 1985 Feb; 134(2):1202-5. PMID: 2981261.
      View in: PubMed
    167. Cochrane AH, Gwadz RW, Ojo-Amaize E, Hii J, Nussenzweig V, Nussenzweig RS. Antigenic diversity of the circumsporozoite proteins in the Plasmodium cynomolgi complex. Mol Biochem Parasitol. 1985 Jan; 14(1):111-24. PMID: 3982450.
      View in: PubMed
    168. Nussenzweig V, Nussenzweig RS. Recent advances in the development of a sporozoite vaccine for malaria. Asian Pac J Allergy Immunol. 1984 Dec; 2(2):289-92. PMID: 6398085.
      View in: PubMed
    169. Gaither TA, Gallin JI, Iida K, Nussenzweig V, Frank MM. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome. Inflammation. 1984 Dec; 8(4):429-44. PMID: 6240460.
      View in: PubMed
    170. Nussenzweig RS, Nussenzweig V. Development of sporozoite vaccines. Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13; 307(1131):117-28. PMID: 6084251.
      View in: PubMed
    171. Schlesinger DH, Cochrane AH, Gwadz RW, Godson GN, Melton R, Nussenzweig RS, Nussenzweig V. Structure of an immunodominant epitope of the circumsporozoite surface protein of Plasmodium knowlesi. Biochemistry. 1984 Nov 06; 23(23):5665-70. PMID: 6210107.
      View in: PubMed
    172. Medof ME, Kinoshita T, Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med. 1984 Nov 01; 160(5):1558-78. PMID: 6238120.
      View in: PubMed
    173. Gysin J, Barnwell J, Schlesinger DH, Nussenzweig V, Nussenzweig RS. Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide. J Exp Med. 1984 Sep 01; 160(3):935-40. PMID: 6470623.
      View in: PubMed
    174. Kinoshita T, Nussenzweig V. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I). J Immunol Methods. 1984 Jul 06; 71(2):247-57. PMID: 6376638.
      View in: PubMed
    175. Medof ME, Nussenzweig V. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1. J Exp Med. 1984 Jun 01; 159(6):1669-85. PMID: 6233387.
      View in: PubMed
    176. Smith GL, Godson GN, Nussenzweig V, Nussenzweig RS, Barnwell J, Moss B. Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science. 1984 Apr 27; 224(4647):397-9. PMID: 6200932.
      View in: PubMed
    177. Nussenzweig V. Synthetic peptides and malaria surface antigens. Ann Sclavo Collana Monogr. 1984; 1(2):187-9. PMID: 6545868.
      View in: PubMed
    178. Ozaki LS, Svec P, Nussenzweig RS, Nussenzweig V, Godson GN. Structure of the plasmodium knowlesi gene coding for the circumsporozoite protein. Cell. 1983 Oct; 34(3):815-22. PMID: 6313209.
      View in: PubMed
    179. Iida K, Nadler L, Nussenzweig V. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med. 1983 Oct 01; 158(4):1021-33. PMID: 6225820.
      View in: PubMed
    180. Godson GN, Ellis J, Svec P, Schlesinger DH, Nussenzweig V. Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein. Nature. 1983 Sep 1-7; 305(5929):29-33. PMID: 6193427.
      View in: PubMed
    181. de Cordoba SR, Ferreira A, Nussenzweig V, Rubinstein P. Genetic polymorphism of human C4-binding protein. J Immunol. 1983 Sep; 131(3):1565-9. PMID: 6886425.
      View in: PubMed
    182. Zavala F, Cochrane AH, Nardin EH, Nussenzweig RS, Nussenzweig V. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med. 1983 Jun 01; 157(6):1947-57. PMID: 6189951.
      View in: PubMed
    183. Emancipator SN, Iida K, Nussenzweig V, Gallo GR. Monoclonal antibodies to human complement receptor (CR1) detect defects in glomerular diseases. Clin Immunol Immunopathol. 1983 May; 27(2):170-5. PMID: 6223755.
      View in: PubMed
    184. Ellis J, Ozaki LS, Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS, Godson GN. Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature. 1983 Apr 07; 302(5908):536-8. PMID: 6339949.
      View in: PubMed
    185. Iida K, Nussenzweig V. Functional properties of membrane-associated complement receptor CR1. J Immunol. 1983 Apr; 130(4):1876-80. PMID: 6220069.
      View in: PubMed
    186. Santoro F, Cochrane AH, Nussenzweig V, Nardin EH, Nussenzweig RS, Gwadz RW, Ferreira A. Structural similarities among the protective antigens of sporozoites from different species of malaria parasites. J Biol Chem. 1983 Mar 10; 258(5):3341-5. PMID: 6338017.
      View in: PubMed
    187. Ferreira A, Nussenzweig V. Murine sex-limited protein (Slp) antigenic sites in human complement component C4. Immunogenetics. 1983; 18(4):335-41. PMID: 6195106.
      View in: PubMed
    188. Medof ME, Iida K, Nussenzweig V. Role of the complement receptor CR1 in the processing of substrate-bound C3. Ann N Y Acad Sci. 1983; 421:299-306. PMID: 6586104.
      View in: PubMed
    189. Medof ME, Iida K, Mold C, Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med. 1982 Dec 01; 156(6):1739-54. PMID: 7175439.
      View in: PubMed
    190. Zavala F, Gwadz RW, Collins FH, Nussenzweig RS, Nussenzweig V. Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes. Nature. 1982 Oct 21; 299(5885):737-8. PMID: 7121602.
      View in: PubMed
    191. Ferreira A, Eichinger D, Nussenzweig V. The murine sex-limited protein (Slp): reassessment of its sex limitation. J Immunol. 1982 Oct; 129(4):1506-8. PMID: 7108216.
      View in: PubMed
    192. Cochrane AH, Santoro F, Nussenzweig V, Gwadz RW, Nussenzweig RS. Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. Proc Natl Acad Sci U S A. 1982 Sep; 79(18):5651-5. PMID: 6957883.
      View in: PubMed
    193. Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med. 1982 Jul 01; 156(1):20-30. PMID: 7045272.
      View in: PubMed
    194. Iida K, Mornaghi R, Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 May 01; 155(5):1427-38. PMID: 6978375.
      View in: PubMed
    195. Hollingdale MR, Zavala F, Nussenzweig RS, Nussenzweig V. Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. J Immunol. 1982 Apr; 128(4):1929-30. PMID: 7037957.
      View in: PubMed
    196. Potocnjak P, Zavala F, Nussenzweig R, Nussenzweig V. Inhibition of idiotype--anti-idiotype interaction for detection of a parasite antigen: a new immunoassay. Science. 1982 Mar 26; 215(4540):1637-9. PMID: 6122269.
      View in: PubMed
    197. Nussenzweig RS, Nussenzweig V. Immunoprophylaxis of malaria: characterization of a protective surface antigen. Harvey Lect. 1982-1983; 78:59-85. PMID: 6151556.
      View in: PubMed
    198. Yoshida N, Potocnjak P, Nussenzweig V, Nussenzweig RS. Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei. J Exp Med. 1981 Oct 01; 154(4):1225-36. PMID: 7026723.
      View in: PubMed
    199. Aikawa M, Yoshida N, Nussenzweig RS, Nussenzweig V. The protective antigen of malarial sporozoites (Plasmodium berghei) is a differentiation antigen. J Immunol. 1981 Jun; 126(6):2494-5. PMID: 6785357.
      View in: PubMed
    200. Iida K, Nussenzweig V. Complement receptor is an inhibitor of the complement cascade. J Exp Med. 1981 May 01; 153(5):1138-50. PMID: 6910481.
      View in: PubMed
    201. Michaelson J, Ferreira A, Nussenzweig V. cis-Interacting genes in the S region of the murine major histocompatibility complex. Nature. 1981 Jan 22; 289(5795):306-8. PMID: 7453827.
      View in: PubMed
    202. Pappas MG, Nussenzweig RS, Nussenzweig V, Shear HL. Complement-mediated defect in clearance and sequestration of sensitized, autologous erythrocytes in rodent malaria. J Clin Invest. 1981 Jan; 67(1):183-92. PMID: 7005263.
      View in: PubMed
    203. Kai S, Fujita T, Gigli I, Nussenzweig V. Mouse C3b/C4b inactivator: purification and properties. J Immunol. 1980 Dec; 125(6):2409-15. PMID: 6776193.
      View in: PubMed
    204. Ferreira A, Michaelson J, Nussenzweig V. A polymorphism of the gamma-chain of mouse C4 controlled by the S region of the major histocompatibility complex. J Immunol. 1980 Sep; 125(3):1178-82. PMID: 7410834.
      View in: PubMed
    205. Potocnjak P, Yoshida N, Nussenzweig RS, Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med. 1980 Jun 01; 151(6):1504-13. PMID: 6991628.
      View in: PubMed
    206. Ferreira A, David CS, Nussenzweig V. The murine H-2.7 specificity is an antigenic determinant of C4d, a fragment of the fourth component of the complement system. J Exp Med. 1980 Jun 01; 151(6):1424-35. PMID: 6155423.
      View in: PubMed
    207. Yoshida N, Nussenzweig RS, Potocnjak P, Nussenzweig V, Aikawa M. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science. 1980 Jan 04; 207(4426):71-3. PMID: 6985745.
      View in: PubMed
    208. Ferreira A, Michaelson J, Nussenzweig V. H-2-controlled polymorphism of the gamma chain of Slp (sex-limited protein). Immunogenetics. 1980; 11(5):491-7. PMID: 6242884.
      View in: PubMed
    209. Ferreira A, Michaelson J, Nussenzweig V. Polymorphism of the gamma chain of murine Ss (C4) and Slp proteins. Immunobiology. 1980; 158(1-2):3-4. PMID: 6162781.
      View in: PubMed
    210. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Nussenzweig V. Danazol's failure to suppress autoimmunity in NZB/NZW F1 mice. Arthritis Rheum. 1979 Dec; 22(12):1399-1402. PMID: 316328.
      View in: PubMed
    211. Gigli I, Fujita T, Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci U S A. 1979 Dec; 76(12):6596-600. PMID: 293746.
      View in: PubMed
    212. Fujita T, Nussenzweig V. The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b. J Exp Med. 1979 Aug 01; 150(2):267-76. PMID: 458376.
      View in: PubMed
    213. Scharfstein J, Nussenzweig V. Cross-species contamination of commercial serum proteins. J Immunol. 1979 May; 122(5):2135. PMID: 87454.
      View in: PubMed
    214. Scharfstein J, Correa EB, Gallo GR, Nussenzweig V. Human C4-binding protein. Association with immune complexes in vitro and in vivo. J Clin Invest. 1979 Mar; 63(3):437-42. PMID: 155077.
      View in: PubMed
    215. Ferreira A, Nussenzweig V. Mouse C4 (Ss): three-step purification of its C4c fragment and production of a monospecific antiserum. J Immunol. 1979 Feb; 122(2):490-3. PMID: 762433.
      View in: PubMed
    216. Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ. 1979; 57 Suppl 1:165-73. PMID: 120766.
      View in: PubMed
    217. Ferreira A, Nussenzweig V, Gigli I. Structural and functional differences between the H-2 controlled Ss and Slp proteins. J Exp Med. 1978 Nov 01; 148(5):1186-97. PMID: 722239.
      View in: PubMed
    218. Fujita T, Gigli I, Nussenzweig V. Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J Exp Med. 1978 Oct 01; 148(4):1044-51. PMID: 702059.
      View in: PubMed
    219. Ferreira A, Weisz-Carrington P, Nussenzweig V. Testosterone control of serum levels of C4-binding protein in mice. J Immunol. 1978 Sep; 121(3):1213-5. PMID: 80430.
      View in: PubMed
    220. Takahashi M, Takahashi S, Brade V, Nussenzweig V. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway. J Clin Invest. 1978 Aug; 62(2):349-58. PMID: 670397.
      View in: PubMed
    221. Scharfstein J, Ferreira A, Gigli I, Nussenzweig V. Human C4-binding protein. I. Isolation and characterization. J Exp Med. 1978 Jul 01; 148(1):207-22. PMID: 670886.
      View in: PubMed
    222. Ferreira A, Takahashi M, Nussenzweig V. Purificaiton and characterization of mouse serum protein with specific binding affinity for C4 (Ss protein). J Exp Med. 1977 Oct 01; 146(4):1001-8. PMID: 894192.
      View in: PubMed
    223. Lustig HJ, Nussenzweig V, Nussenzweig RS. Erythrocyte membrane-associated immunoglobulins during malaria infection of mice. J Immunol. 1977 Jul; 119(1):210-6. PMID: 326956.
      View in: PubMed
    224. Ehlenberger AG, Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977 Feb 01; 145(2):357-71. PMID: 833545.
      View in: PubMed
    225. Takahashi M, Tack BF, Nussenzweig V. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J Exp Med. 1977 Jan 01; 145(1):86-100. PMID: 830792.
      View in: PubMed
    226. Bianco C, Nussenzweig V. Complement receptors. Contemp Top Mol Immunol. 1977; 6:145-76. PMID: 396104.
      View in: PubMed
    227. Ferreira A, Fotino M, Nussenzweig V. Relationship between 4a and 4b HLA-determined specificities and C3 receptors of leukocyte membrane. Eur J Immunol. 1976 Nov; 6(11):832-3. PMID: 1087238.
      View in: PubMed
    228. Ferreira A, Nussenzweig V. Influence of H-2 on the ontogenesis of a spleen cell population which lacks C3 receptors and Thy-1 antigen. J Immunol. 1976 Sep; 117(3):771-3. PMID: 1085310.
      View in: PubMed
    229. Czop J, Nussenzweig V. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med. 1976 Mar 01; 143(3):615-30. PMID: 1249522.
      View in: PubMed
    230. Krettli AU, Nussenzweig V, Nussenzweig RS. Complement alterations in rodent malaria. Am J Trop Med Hyg. 1976 Jan; 25(1):34-41. PMID: 816212.
      View in: PubMed
    231. Takahashi M, Czop J, Ferreira A, Nussenzweig V. Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology. Transplant Rev. 1976; 32:121-39. PMID: 790687.
      View in: PubMed
    232. Ehlenberger AG, McWilliams M, Phillips-Quagliata JM, Lamm ME, Nussenzweig V. Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood. J Clin Invest. 1976 Jan; 57(1):53-6. PMID: 1081992.
      View in: PubMed
    233. Rabinovitch M, Manejias RE, Nussenzweig V. Selective phagocytic paralysis induced by immobilized immune complexes. J Exp Med. 1975 Oct 01; 142(4):827-38. PMID: 1185106.
      View in: PubMed
    234. Miller GW, Steinberg AD, Green I, Nussenzweig V. Complement-dependent alterations in the handling of immune complexes by NZB/W mice. J Immunol. 1975 Apr; 114(4):1166-70. PMID: 1117137.
      View in: PubMed
    235. Ferreira A, Nussenzweig V. Genetic linkage between serum levels of the third component of complement and the H-2 complex. J Exp Med. 1975 Feb 01; 141(2):513-7. PMID: 1113067.
      View in: PubMed
    236. Miller GW, Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975 Feb; 72(2):418-22. PMID: 1054824.
      View in: PubMed
    237. Miller GW, Nussenzweig V. Complement as a regulator of interactions between immune complexes and cell membranes. J Immunol. 1974 Aug; 113(2):464-9. PMID: 4845664.
      View in: PubMed
    238. Nussenzweig V. Receptors for immune complexes on lymphocytes. Adv Immunol. 1974; 19(0):217-58. PMID: 4611172.
      View in: PubMed
    239. Eden A, Miller GW, Nussenzweig V. Human lymphocytes bear membrane receptors for C3b and C3d. J Clin Invest. 1973 Dec; 52(12):3239-42. PMID: 4543024.
      View in: PubMed
    240. Weiner MS, Bianco C, Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec; 42(6):939-46. PMID: 4357270.
      View in: PubMed
    241. Miller GW, Saluk PH, Nussenzweig V. Complement-dependent release of immune complexes from the lymphocyte membrane. J Exp Med. 1973 Sep 01; 138(3):495-507. PMID: 4542253.
      View in: PubMed
    242. Eden A, Bianco C, Bogart B, Nussenzweig V. Interaction and release of soulble immune complexes from mouse B luymphocytes. Cell Immunol. 1973 Jun; 7(3):474-83. PMID: 4541629.
      View in: PubMed
    243. Eden A, Bianco C, Nussenzweig V, Mayer MM. C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol. 1973 May; 110(5):1452-3. PMID: 4540538.
      View in: PubMed
    244. Broome JD, Zucker-Franklin D, Weiner MS, Bianco C, Nussenzweig V. Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. Clin Immunol Immunopathol. 1973 Apr; 1(3):319-29. PMID: 4270688.
      View in: PubMed
    245. Pincus C, Miller G, Nussenzweig V. Enhancement of an anti-hapten antibody response by an antiserum to the carrier protein. J Immunol. 1973 Jan; 110(1):301-4. PMID: 4685408.
      View in: PubMed
    246. Pincus S, Bianco C, Nussenzweig V. Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. Blood. 1972 Sep; 40(3):303-10. PMID: 5066536.
      View in: PubMed
    247. Vitetta ES, Bianco C, Nussenzweig V, Uhr JW. Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med. 1972 Jul 01; 136(1):81-93. PMID: 5064226.
      View in: PubMed
    248. Chen LT, Eden A, Nussenzweig V, Weiss L. Electron microscopic study of the lymphocytes capable of binding antigen-antibody-complement complexes. Cell Immunol. 1972 Jul; 4(3):279-88. PMID: 5037347.
      View in: PubMed
    249. Eden A, Lamm ME, Nussenzweig V. Complementarity of H and L chains from antihapten antibodies of different classes. J Immunol. 1972 Jun; 108(6):1605-8. PMID: 5064049.
      View in: PubMed
    250. Mantovani B, Rabinovitch M, Nussenzweig V. Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med. 1972 Apr 01; 135(4):780-92. PMID: 5018051.
      View in: PubMed
    251. Eden A, Bianco C, Nussenzweig V. A population of lymphocytes bearing a membrane receptor antigen-antibody-complement complexes. II. Specific isolation. Cell Immunol. 1971 Dec; 2(6):658-69. PMID: 5317411.
      View in: PubMed
    252. Dukor P, Bianco C, Nussenzweig V. Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol. 1971 Dec; 1(6):491-4. PMID: 5147490.
      View in: PubMed
    253. Nussenzweig V. Complement-receptor lymphocytes. Am J Pathol. 1971 Nov; 65(2):479-80. PMID: 19971049.
      View in: PubMed
    254. Bianco C, Nussenzweig V. Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science. 1971 Jul 09; 173(3992):154-6. PMID: 5581911.
      View in: PubMed
    255. Pincus CS, Lamm ME, Nussenzweig V. Regulation of the immune response: suppressive and enhancing effects of passively administered antibody. J Exp Med. 1971 May 01; 133(5):987-1003. PMID: 4101806.
      View in: PubMed
    256. Lay WH, Mendes NF, Bianco C, Nussenzweig V. Binding of sheep red blood cells to a large population of human lymphocytes. Nature. 1971 Apr 23; 230(5295):531-2. PMID: 4927757.
      View in: PubMed
    257. Nussenzweig V, Green I. Lack of correlation between the net charge of antigen and antibodies in guinea pigs immunized with some charged antigens. J Immunol. 1971 Apr; 106(4):1089-94. PMID: 4101775.
      View in: PubMed
    258. Dukor P, Bianco C, Nussenzweig V. Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Proc Natl Acad Sci U S A. 1970 Oct; 67(2):991-7. PMID: 5289036.
      View in: PubMed
    259. Bianco C, Patrick R, Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 01; 132(4):702-20. PMID: 4101362.
      View in: PubMed
    260. Nussenzweig V, Benacerraf B, Ovary Z. Further evidence of the role of gamma 1 guinea pig antibodies in mediating passive cutaneous anaphylaxis (PCA). J Immunol. 1969 Nov; 103(5):1152-4. PMID: 4187115.
      View in: PubMed
    261. Pincus CS, Nussenzweig V. Passive antibody may simultaneously suppress and stimulate antibody formation against different portions of a protein molecule. Nature. 1969 May 10; 222(5193):594-6. PMID: 5305867.
      View in: PubMed
    262. Lay WH, Nussenzweig V. Ca++-dependent binding of antigen-19 S antibody complexes to macrophages. J Immunol. 1969 May; 102(5):1172-8. PMID: 5814168.
      View in: PubMed
    263. Benacerraf B, Nussenzweig V, Maurer PH, Stylos W. Relationship between the net electrical charge of antigens and specific antibodies. An example of selection by antigen of cells producing highest affinity antibody. Isr J Med Sci. 1969 Mar-Apr; 5(2):171-6. PMID: 4184816.
      View in: PubMed
    264. Lay WH, Nussenzweig V. Receptors for complement of leukocytes. J Exp Med. 1968 Nov 01; 128(5):991-1009. PMID: 4176227.
      View in: PubMed
    265. Keller HU, Nussenzweig V, Sorkin E. Studies on chemotaxis. 8. The role of 7S-gamma-1 and 7S-gamma-2 guinea-pig antibodies for chemotaxis in granulocytes. Immunochemistry. 1968 May; 5(3):293-5. PMID: 5666029.
      View in: PubMed
    266. Nussenzweig V, Green I, Vassalli P, Benacerraf B. Changes in the proportion of guinea-pig gamma-1 and gamma-2 antibodies during immunization and the cellular localization of these immunoglobulins. Immunology. 1968 May; 14(5):601-9. PMID: 4872344.
      View in: PubMed
    267. Nussenzweig V, Benacerraf B. Antihapten antibody specificity and L chain type. J Exp Med. 1967 Oct 01; 126(4):727-43. PMID: 4168100.
      View in: PubMed
    268. Lamm ME, Lisowska-Bernstein B, Nussenzweig V. Comparison of guinea pig gamma 1-and gamma 2-immunoglobulins by peptide mapping. Biochemistry. 1967 Sep; 6(9):2819-28. PMID: 4168042.
      View in: PubMed
    269. Green I, Vassalli P, Nussenzweig V, Benacerraf B. Specificity of the antibodies produced by single cells following immunization with antigens bearing two types of antigenic determinants. J Exp Med. 1967 Mar 01; 125(3):511-26. PMID: 4163363.
      View in: PubMed
    270. Nussenzweig V, Benacerraf B. Quantitative variations in L chain types in guinea pig antihapten antibodies. J Exp Med. 1966 Nov 01; 124(5):805-18. PMID: 4162733.
      View in: PubMed
    271. Nussenzweig V, Lamm ME, Benacerraf B. Presence of two types of L polypeptide chains in guinea pig 7S immunoglobulins. J Exp Med. 1966 Nov 01; 124(5):787-803. PMID: 4959010.
      View in: PubMed
    272. Nussenzweig V, Benacerraf B. Presence of identical antigenic determinants in the Fd fragments of gamma-1- and gamma-2-guinea pig immunoglobulins. J Immunol. 1966 Aug; 97(2):171-6. PMID: 4162285.
      View in: PubMed
    273. Lamm ME, Nussenzweig V, Benacerraf B. Isolation of purified H and L polypeptide chains from guinea-pig gamma-2-immunoglobulin after mild reduction. Immunology. 1966 Apr; 10(4):309-19. PMID: 4160443.
      View in: PubMed
    274. NUSSENZWEIG V, BENACERRAF B. ELECTROPHORETIC PATTERNS AT ACID AND ALKALINE PH OF REDUCED GUINEA-PIG 7 S GAMMA GLOBULIN AND ANTI-HAPTEN ANTIBODIES OF DIFFERENT SPECIFICITIES. Int Arch Allergy Appl Immunol. 1965; 27:193-8. PMID: 14315113.
      View in: PubMed
    275. Nussenzweig V, Binaghi RA. Heterogeneity of rat immunoglobulins. Int Arch Allergy Appl Immunol. 1965; 27(6):355-60. PMID: 4158079.
      View in: PubMed
    276. NUSSENZWEIG V, BENACERRAF B. STUDIES ON THE PROPERTIES OF FRAGMENTS OF GUINEA PIG GAMMA-1 AND GAMMA-2 ANTIBODIES OBTAINED BY PAPAIN DIGESTION AND MILD REDUCTION. J Immunol. 1964 Dec; 93:1008-14. PMID: 14241758.
      View in: PubMed
    277. NUSSENZWEIG V, BENACERRAF B. DIFFERENCES IN THE ELECTROPHORETIC MOBILITIES OF GUINEA PIG 7S ANTIBODIES OF DIFFERENT SPECIFICITIES. J Exp Med. 1964 Mar 01; 119:409-23. PMID: 14129712.
      View in: PubMed
    278. WARMBRAND M, NUSSENZWEIG V, FERNANDES JF. EFFECT OF THE AMINONUCLEOSIDE OF STYLOMYCIN AND PRIMAQUINE ON THE SYNTHESIS OF ANTI EGG ALBUMIN BY RABBITS. Rev Inst Med Trop Sao Paulo. 1963 Nov-Dec; 5:294-6. PMID: 14116865.
      View in: PubMed
    279. NUSSENZWEIG V, DEANE LM, KLOETZEL J. DIFFERENCES IN ANTIGENIC CONSTITUTION OF STRAINS OF TRYPANOSOMA CRUZI. Exp Parasitol. 1963 Oct; 14:221-32. PMID: 14072768.
      View in: PubMed
    280. NUSSENZWEIG V, KLOETZEL J, DEANE LM. ACQUIRED IMMUNITY IN MICE INFECTED WITH STRAINS OF IMMUNOLOGICAL TYPES A AND B OF TRYPANOSOMA CRUZI. Exp Parasitol. 1963 Oct; 14:233-9. PMID: 14072769.
      View in: PubMed
    281. NUSSENZWEIG V, DEANE LM, KLOETZEL J. [Difference in the antigenic composition of Trypanosoma cruzi strains isolated from man and opossums. (Preliminary note)]. Rev Inst Med Trop Sao Paulo. 1962 Nov-Dec; 4:409-10. PMID: 13939268.
      View in: PubMed
    282. NUSSENZWEIG V, DE SOUZA EA. Cross reaction studies in a protein-antiprotein system. The immunochemical relationship between two isolated components of digested human fibrinogen with bovine fibrinogen. Int Arch Allergy Appl Immunol. 1962; 21:294-304. PMID: 13939269.
      View in: PubMed
    283. NUSSENZWEIG V, SELIGMANN M, GRABAR P. [The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities]. Ann Inst Pasteur (Paris). 1961 Apr; 100:490-508. PMID: 13729933.
      View in: PubMed
    284. NUSSENZWEIG V, SELIGMANN M, PELMONT J, GRABAR P. [The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties]. Ann Inst Pasteur (Paris). 1961 Mar; 100:377-89. PMID: 13729934.
      View in: PubMed
    285. NUSSENZWEIG V, SELIGMANN M. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages]. Nouv Rev Fr Hematol. 1960 Nov-Dec; 15:451-66. PMID: 13729935.
      View in: PubMed
    286. NUSSENZWEIG V, AMATO NETO V, MELLONE O. [Recent data on the use of gentian violet in prevention of the transmission of Chagas'disease by blood transfusion]. Hospital (Rio J). 1959 Feb; 55(2):183-8. PMID: 13640534.
      View in: PubMed
    287. NUSSENZWEIG V, NUSSENZWEIG RS, DE FREITAS JL, AMATO NETO V, BIANCALANA A, KLOETZEL J. [Effects of physical and chemical agents of Trypanosoma cruzi in vitro]. Hospital (Rio J). 1954 May; 45(5):589-99. PMID: 13183561.
      View in: PubMed
    288. BIANCALANA A, DE FREITAS JL, AMATO NETO V, NUSSENZWEIG V, SONNTAG R. [Blood tests for Chagas disease in prospective donors in blood banks in the states of São Paulo and Minas Gerais]. Hospital (Rio J). 1953 Dec; 44(6):745-9. PMID: 13151631.
      View in: PubMed
    289. NUSSENZWEIG V, SONNTAG R, BIANCALANA A, DE FREITAS JL, AMATO NETO V, KLOETZEL J. [Effect of triphenylmethane dyes on Trypanosoma cruzi in vitro; use of gentian violet in prevention of transmission of Chagas disease by blood transfusion]. Hospital (Rio J). 1953 Dec; 44(6):731-44. PMID: 13151630.
      View in: PubMed
    290. NUSSENZWEIG V, BIANCALANA A, AMATO NETO V, SONNTAG R, DE FREITAS JP, KLOETZEL J. [Effect of gentian violet on Trypanosoma cruzi in vitro; importance in the sterilization of blood for transfusion]. Rev Paul Med. 1953 Jan; 42(1):57-8. PMID: 13075109.
      View in: PubMed
    291. DE FREITAS JP, BIANCALANA A, AMATO NETO V, NUSSENZWEIG V, SONNTAG R, BARRETTO JG. [Chagas' disease in blood banks in the capital of São Paulo]. Hospital (Rio J). 1952 Feb; 41(2):229-36. PMID: 13068944.
      View in: PubMed
    Nussenzweig's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description